共 50 条
- [21] Patterns of acquired resistance to anti-PD-1 antibodies in patients with metastatic melanoma (MM).JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)Lee, Jenny H. J.Cooper, Adam JamesLyle, Megan KateLiniker, ElizabethMenzies, Alexander M.Kefford, RichardLong, Georgina V.Carlino, Matteo S.
- [22] Dietary fish oil and aspirin to augment anti-PD-1 immunotherapy in metastatic melanomaCANCER RESEARCH, 2022, 82 (12)Chacon, Alexander C.Qin, Shuyang S.Melucci, Alexa D.Jackson, Katherine M.Burchard, Paul R.Dave, Yatee A.Jewell, RachelBelt, Brian A.Tabayoyong, WilliamLinehan, David C.Prieto, Peter A.
- [23] Focal regression of a primary melanoma, fading lentigines and poliosis in metastatic melanoma treated with anti-PD-1JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2018, 32 (05) : E176 - E177Thomas, S.Laino, A.Sturm, R.Nufer, K.Lambie, D.Shepherd, B.Atkinson, V.Adams, L.Soyer, H. P.Schaider, H.
- [24] Hepatic Radiotherapy in Addition to Anti-PD-1 for the Treatment of Metastatic Uveal Melanoma PatientsCANCERS, 2023, 15 (02)Rossi, ErnestoCellini, FrancescoPagliara, Monica MariaSammarco, Maria GraziaPedone, Romina RoseLancellotta, ValentinaTagliaferri, LucaQuirino, MichelaGambacorta, Maria AntoniettaBlasi, Maria AntoniettaTortora, GiampaoloSchinzari, Giovanni
- [25] Anti-PD-1 immunotherapy in advanced metastatic melanoma: State of the art and future challengesLIFE SCIENCES, 2020, 240Moreira, Rita S.Bicker, JoanaMusicco, FelicePersichetti, AgnesePereira, Andre M. P. T.
- [26] Lichenoid Dermatitis in Three Patients with Metastatic Melanoma Treated with Anti-PD-1 TherapyCANCER IMMUNOLOGY RESEARCH, 2015, 3 (01) : 18 - 22Joseph, Richard W.Cappel, MarkGoedjen, BrentGordon, MatthewKirsch, BrandonGilstrap, CherylBagaria, SanjayJambusaria-Pahlajani, Anokhi
- [27] Clinical, histological and molecular predictors of metastatic melanoma responses to anti-PD-1 immunotherapyBRITISH JOURNAL OF CANCER, 2018, 119 (02) : 193 - 199Dupuis, FrantzLamant, LaurenceGerard, EmilieTorossian, NouritzaChaltiel, LeonorFilleron, ThomasBeylot-Barry, MarieDutriaux, CarolinePrey, SorillaGros, AudreyJullie, Marie-LaureMeyer, NicolasVergier, Beatrice
- [28] Activity and safety of radiotherapy with anti-PD-1 drug therapy in patients with metastatic melanomaONCOIMMUNOLOGY, 2016, 5 (09):Liniker, E.Menzies, A. M.Kong, B. Y.Cooper, A.Ramanujam, S.Lo, S.Kefford, R. F.Fogarty, G. B.Guminski, A.Wang, T. W.Carlino, M. S.Hong, A.Long, G. V.
- [29] PD-L1 is a biomarker of real-world clinical outcomes for anti-CTLA-4 plus anti-PD-1 or anti-PD-1 monotherapy in metastatic melanomaEUROPEAN JOURNAL OF CANCER, 2024, 198Ellebaek, EvaKhan, ShawezBastholt, LarsSchmidt, HenrikHaslund, Charlotte AaquistDonia, MarcoSvane, Inge Marie
- [30] Treatment of metastatic melanoma with anti-PD-1 and anti-LAG-3 in a kidney transplant recipientIMMUNOTHERAPY, 2025, 17 (03) : 179 - 184Patel, Janmesh D.Zhong, WeixiongSchulte, Jefree J.Garg, NeetikaBirbrair, AlexanderPleva, JenniferMa, Vincent T.